Latest Sulfonamides Stories
Expanded Policy will Increase Access for Darunavir Pediatric Formulations in 128 Resource-Limited Countries RARITAN, N.J., May 11, 2015 /PRNewswire/ -- Johnson & Johnson today
FDA Approves Labeling Supplement WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc.
RnRMarketResearch.com adds "Pulmonary Hypertension - Pipeline Review, H1 2015" to its store.
SARATOGA, Calif., March 18, 2015 /PRNewswire/ -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused
Combined Fixed-Dose Tablet of Darunavir and Cobicistat Can Help Reduce Number of Pills in a Combination Antiretroviral Treatment Regimen TITUSVILLE, N.J., Jan.
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 7, 2014 /PRNewswire/ - Cardiome Pharma Corp.
NEW YORK, Oct.
BEERSE, Belgium, September 29, 2014 /PRNewswire/ -- CHMP also issues two label extensions for darunavir Janssen-Cilag International NV (Janssen)
New Treatment Option Combining Protease Inhibitor and Boosting Agent Reduces the Number of Pills Required to Manage HIV TORONTO, Sept. 17, 2014 /CNW/ - Janssen Inc.
- A hairdresser.